Florida Senate - 2012 SB 324 By Senator Bullard 39-00273-12 2012324__ 1 A bill to be entitled 2 An act relating to congenital craniofacial anomalies; 3 requiring the Agency for Health Care Administration, 4 in consultation with the Office of Insurance 5 Regulation, to conduct a study concerning the medical 6 necessity, costs, and efficacy of mandating coverage 7 for certain treatments and therapies; requiring that 8 the agency report its findings and recommendations to 9 the Legislature; providing an appropriation; providing 10 an effective date. 11 12 Be It Enacted by the Legislature of the State of Florida: 13 14 Section 1. (1) The Agency for Health Care Administration, 15 in consultation with the Office of Insurance Regulation, shall 16 conduct a study evaluating the medical necessity, efficacy, and 17 costs of requiring health insurers and health maintenance 18 organizations to provide coverage for cranial-skull-molding 19 orthotics and other therapies used in the treatment of 20 deformational or positional plagiocephaly. The agency and office 21 shall evaluate whether gaps in coverage currently exist in the 22 small and large group insurance markets for medically necessary 23 care and treatment of plagiocephaly. The agency shall provide 24 information concerning the types of benefits, including the cost 25 of such benefits, provided to Medicaid recipients for the 26 treatment of plagiocephaly and the demographic characteristics 27 of such Medicaid recipients. The Department of Health shall 28 coordinate with the agency to provide such information 29 concerning coverage and the costs of providing such coverage to 30 children who have plagiocephaly and who are enrolled in the 31 Children’s Medical Services Program. 32 (2) The agency, in consultation with the office, may 33 contract with an actuary who is a member of the American Academy 34 of Actuaries and other persons who have an extensive background 35 in health insurance for the purpose of assisting the agency in 36 evaluating the medical necessity, efficacy, and costs of such 37 coverage. The agency shall report its findings and 38 recommendations related to mandating insurance coverage for the 39 treatment of plagiocephaly to the President of the Senate and 40 the Speaker of the House of Representatives by January 1, 2013. 41 Section 2. For the 2012-2013 fiscal year, the sum of 42 $25,000 is appropriated in nonrecurring funds from the Insurance 43 Regulatory Trust Fund to the Office of Insurance Regulation for 44 the purpose of funding the study conducted by the Agency for 45 Health Care Administration as provided in this act. 46 Section 3. This act shall take effect July 1, 2012.